4-Fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1-(2-(trifluoromethyl)pyridin-4-yl)-1H-isoindol-3-amine
4-Fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1-(2-(trifluoromethyl)pyridin-4-yl)-1H-isoindol-3-amine, with the potential to treat Alzheimer's disease, was reported as a selective BACE1 inhibitor (IC50=4.8μM) for which concentration-dependent lowering of Ab peptides in cellular systems and three pre-clinical species were demonstrated. Phase-I for Alzheimer's disease in United Kingdom (PO) was discontinued in 2012 in UK.
| Supplier | BOC Sciences |
|---|---|
| Product # | 1227163-56-5 |
| Pricing | Inquire |
| Cas | 1227163-56-5 |
| Molecular Weight | 449.40 |
| Molecular Formula | C24H15F4N5 |
| Canonical SMILES | C1=CC(=CC(=C1)C2(C3=C(C(N2)N)C(=CC=C3)F)C4=CC(=NC=C4)C(F)F)C5=CN=CN=C5 |